v3.26.1
Condensed Consolidated Statements of Income/ (Loss) and Comprehensive Income/ Loss (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Income Statement [Abstract]    
Net Sales $ 1,781,721 $ 2,635,718
Cost of Sales 899,252 1,431,484
Gross Profit 882,469 1,204,234
Operating Expenses    
Selling expenses 369,425 327,596
General and administrative expenses 1,047,897 1,069,608
Research and development 390
Total Operating Expenses 1,417,322 1,397,594
Loss From Operations (534,853) (193,360)
Other Income (Expenses)    
Non-operating income 4,909 76,893
Loss on impairment of goodwill (218,606)
Unrealized gain 794,212
Foreign exchange transaction loss (3,987)
Interest expense, net (35,068) (7,762)
Financial expense (37,686) (54,309)
Total Other Income (Expenses), Net 726,367 (207,771)
Income (Loss) Before Income Taxes 191,514 (401,131)
Income Tax Benefit 62,260
Net Income (Loss) 191,514 (338,871)
Other Comprehensive Loss    
Foreign currency translation (2,975)
Net Income (Loss) and Comprehensive Income (Loss) $ 191,514 $ (341,846)
Weighted average shares outstanding - Basic [1] 44,829,706 9,780,576
Weighted average shares outstanding - Diluted [1] 44,829,706 9,780,576
Net income (loss) per share of common stock    
Basic $ 0.00 $ (0.03)
Diluted $ 0.00 $ (0.03)
[1] Including 10,458,000 and 501,550 shares that were granted and vested but not yet issued for the three months ended March 31, 2026 and 2025, respectively.